首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis.
【24h】

Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis.

机译:持续性变应性鼻炎患者外周血中的变应原特异性分泌IL-10的I型T调节细胞而非CD4(+)CD25(+)Foxp3(+)T细胞减少。

获取原文
获取原文并翻译 | 示例
       

摘要

We investigate the frequencies of CD4(+)CD25(+)Foxp3(+) T cells and allergen-specific IL-10(+)IL-4(-), IFN-gamma(+)IL-4(-), IL-4(+)IFN-gamma(-)CD4(+) T cells (which display characteristics of nTreg, Tr1-, Th1- and Th2- cells, respectively) in peripheral blood mononuclear cells (PBMCs) of patients with AR and of healthy individuals. In addition, we estimated the suppressive effect of CD4(+)CD25(+) Treg cells and allergen-specific, IL-10-secreting cells from both two groups. The frequency of CD4(+)CD25(+)Foxp3(+) T cells is similar in 43 AR patients compared with 38 healthy subjects. CD4(+)CD25(high) cells retain suppressive activity on allergen-stimulated cell proliferation and cytokine production of Th1 but not Th2 cells in both groups. However, the frequency of allergen-specific IL-10(+)IL-4(-)CD4(+) T cells is reduced in AR patients, and correlates inversely to clinical symptom scores. Allergen-specific, IL-10-secreting cells potently suppressed D. pteronyssinus major allergen 1-stimulated cell proliferation and cytokine production (IFN-gamma and IL-4) in healthy individuals. Altogether our data indicate that the number and function of CD4(+)CD25(+) Treg cells from allergic patients are not impaired. However, the deficiency of allergen-specific Tr1 cells may play a role in the development of AR.
机译:我们调查CD4(+)CD25(+)Foxp3(+)T细胞和过敏原特异性IL-10(+)IL-4(-),IFN-γ(+)IL-4(-),IL的频率患有AR和HBV的患者外周血单个核细胞(PBMC)中的-4(+)IFN-γ(-)CD4(+)T细胞(分别显示nTreg,Tr1,Th1-和Th2-细胞的特征)健康的个体。此外,我们估计了两组CD4(+)CD25(+)Treg细胞和过敏原特异性IL-10分泌细胞的抑制作用。与38例健康受试者相比,43例AR患者中CD4(+)CD25(+)Foxp3(+)T细胞的频率相似。 CD4(+)CD25(high)细胞在两组中都保留了对变应原刺激的Th1细胞增殖和细胞因子产生的抑制活性,但对Th2细胞没有抑制作用。但是,在AR患者中,变应原特异性IL-10(+)IL-4(-)CD4(+)T细胞的频率降低,并且与临床症状评分成反比。过敏原特异性,分泌IL-10的细胞有效抑制了D.pteronyssinus主要过敏原1刺激了健康个体的细胞增殖和细胞因子生成(IFN-γ和IL-4)。总的来说,我们的数据表明,来自过敏患者的CD4(+)CD25(+)Treg细胞的数量和功能没有受到损害。但是,过敏原特异的Tr1细胞的缺乏可能在AR的发展中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号